A Native American tribe says it expects more deals with pharma companies looking to protect patents, following a multi-million dollar deal that could hinder generic competition for an Allergan dry ...

Lying in wait at the moment are well-entrenched therapies like Novartis' Xiidra (lifitegrast) and AbbVie's Restasis (cyclosporine ... a shake-up with low-cost generic competitors to Restasis ...

The Prosthetic Replacement of Ocular Surface Ecosystem was well-tolerated and appeared efficacious as a delivery system for ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

Cialis and its generic counterpart, tadalafil, have Food and Drug Administration (FDA) approval to treat erectile dysfunction. Learn more about our most trusted places to get this medication ...

Erectile dysfunction (ED) is a common condition, and many people find that it is treatable with Viagra — sometimes called the “little blue pill” — and its generic form, sildenafil.

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...